MassDevice.com +5 | The top 5 medtech stories for June 15, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Biotronik wins CE Mark for Magmaris bioresorbable scaffold
Biotronik said today it won CE Mark for its Magmaris magnesium bioresorbable scaffold designed to treat coronary artery disease.
Data from the Biosolve-II trial of the stent was previously published in The Lancet, the company said, and 1-year data examining the safety of the device was recently published in The European Heart Journal. Read more
4. Silk Road touts TCAR study data
Silk Road Medical disclosed encouraging new clinical data for its Enroute device, which is cleared to help protect the brain from stroke while implanting a transcarotid artery stent.
The company said that additional data showed its Enroute transcarotid neuroprotection and stent system, indicated for transcarotid artery revascularization (TCAR), helped improve stroke and death rates in the wake of its FDA sign-off last October. Investigators from Massachusetts General Hospital and elsewhere presented their findings during the 2016 Vascular Annual Meeting of the Society for Vascular Surgery, which was held June 8-11 in National Harbor, MD.&nb...
Source: Mass Device - Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
More News: Brain | Cardiology | Diabetes | Endocrinology | Health | Heart | Heart Valve Surgery | Hospital Management | Hospitals | Legislation | Magnesium | Medical Devices | Neurology | Neurosurgery | Partnerships | Stroke | Study